Literature DB >> 17907284

Genetic epidemiology of primary sclerosing cholangitis.

Tom-H Karlsen1, Erik Schrumpf, Kirsten-Muri Boberg.   

Abstract

The aetiology of primary sclerosing cholangitis (PSC) is not known. A more than 80-fold increased risk of PSC among first-degree relatives emphasizes the importance of genetic factors. Genetic associations within the human leukocyte antigen (HLA) complex on chromosome 6p21 were detected in PSC 25 years ago. Subsequent studies have substantiated beyond doubt that one or more genetic variants located within this genetic region are important. The true identities of these variants, however, remain to be identified. Several candidate genes at other chromosomal loci have also been investigated. However, according to strict criteria for what may be denominated a susceptibility gene in complex diseases, no such gene exists for PSC today. This review summarises present knowledge on the genetic susceptibility to PSC, as well as genetic associations with disease progression and clinical subsets of particular interest (inflammatory bowel disease and cholangiocarcinoma).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907284      PMCID: PMC4171275          DOI: 10.3748/wjg.v13.i41.5421

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  128 in total

Review 1.  How many diseases does it take to map a gene with SNPs?

Authors:  K M Weiss; J D Terwilliger
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

2.  Primary sclerosing cholangitis; review and report of six cases.

Authors:  S I SCHWARTZ; W A DALE
Journal:  AMA Arch Surg       Date:  1958-09

Review 3.  Finding genes that underlie complex traits.

Authors:  Anne M Glazier; Joseph H Nadeau; Timothy J Aitman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

4.  No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Authors:  Kristine Wiencke; Kirsten Muri Boberg; Peter Donaldson; Hanne Harbo; Vincent Ling; Erik Schrumpf; Anne Spurkland
Journal:  Scand J Gastroenterol       Date:  2006-05       Impact factor: 2.423

5.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.

Authors:  G-T Ho; N Soranzo; E R Nimmo; A Tenesa; D B Goldstein; J Satsangi
Journal:  Hum Mol Genet       Date:  2006-01-24       Impact factor: 6.150

6.  The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.

Authors:  E Melum; T H Karlsen; U Broomé; E Thorsby; E Schrumpf; K M Boberg; B A Lie
Journal:  Tissue Antigens       Date:  2006-07

7.  Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Authors:  K Hata; D H Van Thiel; R B Herberman; T L Whiteside
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

8.  Risk factors in primary sclerosing cholangitis.

Authors:  E Schrumpf; M Abdelnoor; O Fausa; K Elgjo; E Jenssen; F Kolmannskog
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

9.  Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver.

Authors:  A Escorsell; A Parés; J Rodés; J A Solís-Herruzo; M Miras; E de la Morena
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

Review 10.  Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease.

Authors:  R Dawkins; C Leelayuwat; S Gaudieri; G Tay; J Hui; S Cattley; P Martinez; J Kulski
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

View more
  18 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

2.  Hepatopancreatobiliary manifestations of inflammatory bowel disease.

Authors:  Kazuhiko Nakamura; Tetsuhide Ito; Kazuhiro Kotoh; Eikichi Ihara; Haruei Ogino; Tsutomu Iwasa; Yoshimasa Tanaka; Yoichiro Iboshi; Ryoichi Takayanagi
Journal:  Clin J Gastroenterol       Date:  2012-01-06

3.  Sclerosing cholangitis: pediatric perspective.

Authors:  Nanda Kerkar; Tamir Miloh
Journal:  Curr Gastroenterol Rep       Date:  2010-06

Review 4.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

5.  Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.

Authors:  Brian D Juran; Elizabeth J Atkinson; Erik M Schlicht; Joseph J Larson; David Ellinghaus; Andre Franke; Konstantinos N Lazaridis
Journal:  Liver Int       Date:  2010-12-07       Impact factor: 5.828

6.  Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.

Authors:  Marcel Janse; Laetitia E Lamberts; Lude Franke; Soumya Raychaudhuri; Eva Ellinghaus; Kirsten Muri Boberg; Espen Melum; Trine Folseraas; Erik Schrumpf; Annika Bergquist; Einar Björnsson; Jingyuan Fu; Harm Jan Westra; Harry J M Groen; Rudolf S N Fehrmann; Joanna Smolonska; Leonard H van den Berg; Roel A Ophoff; Robert J Porte; Tobias J Weismüller; Jochen Wedemeyer; Christoph Schramm; Martina Sterneck; Rainer Günther; Felix Braun; Severine Vermeire; Liesbet Henckaerts; Cisca Wijmenga; Cyriel Y Ponsioen; Stefan Schreiber; Tom H Karlsen; Andre Franke; Rinse K Weersma
Journal:  Hepatology       Date:  2011-05-02       Impact factor: 17.425

Review 7.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

8.  Genome-wide association studies--a summary for the clinical gastroenterologist.

Authors:  Espen Melum; Andre Franke; Tom H Karlsen
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

Review 9.  Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?

Authors:  Ulrich Beuers; Gerd A Kullak-Ublick; Thomas Pusl; Erik R Rauws; Christian Rust
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.